Dan G. Duda

Oct 25, 2024 | nature.com | Xin L. Liu |Dan G. Duda

Tertiary lymphoid structures (TLS) have different stages and cellular compositions in human tumors. New data are showing the effect of neoadjuvant immunotherapy on the fate of TLS in treatment-responsive versus treatment-resistant liver cancers.

Aug 18, 2024 | nature.com | Konstantine Tchourine |Keene L. Abbott |Florian Gourgue |Brian T. Do |Tenzin Kunchok |Allison Lau | +9 more

AbstractMetastases arise from subsets of cancer cells that disseminate from the primary tumour1,2. The ability of cancer cells to thrive in a new tissue site is influenced by genetic and epigenetic changes that are important for disease initiation and progression, but these factors alone do not predict if and where cancers metastasize3,4. Specific cancer types metastasize to consistent subsets of tissues, suggesting that primary tumour-associated factors influence where cancers can grow.

Mar 7, 2023 | gut.bmj.com | Satoru Morita |Dan G. Duda

http://orcid.org/0000-0002-5551-8662Satoru Morita, http://orcid.org/0000-0001-7065-8797Dan G Duda Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts, USA Correspondence to Dr Dan G Duda, Radiation Oncology, Massachusetts General Hospital, Boston, MA 02114, USA; duda{at}steele.mgh.harvard.edu Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s...